Sydney: A new type of vaccine targeting tuberculosis (TB) has been successfully developed and tested by researchers. The early-stage vaccine which was shown to provide substantial protection against TB in a pre-clinical laboratory setting was published in the Journal of Medicinal Chemistry.

Study co-author Anneliese Ashhurst, who is affiliated with both the Centenary Institute and the University of Sydney said that tuberculosis is a huge world-wide health problem which is caused by a bacteria that infects the lungs after it's inhaled. It is contagious and results in approximately 1.6 million deaths per year globally.